Derma Sciences, Inc. (DSCI) Reports First Quarter 2013 Financial Results
5/16/2013 9:10:01 AM
More...
|
Derma Sciences, Inc. (DSCI) Engages Plexus Ventures to Explore Strategic Options for DSC127 Outside the U.S.
5/14/2013 10:00:33 AM
More...
|
Derma Sciences, Inc. (DSCI) Begins Screening Patients in Second Phase 3 Trial With DSC127 for Healing Diabetic Foot Ulcers
4/26/2013 10:12:16 AM
More...
|
Derma Sciences, Inc. (DSCI) to Present at the 12th Annual Needham Healthcare Conference
4/23/2013 6:29:40 AM
More...
|
Derma Sciences, Inc. (DSCI) Expands TCC-EZ® Market Reach With Long-Term Exclusive Global Rights Agreement
4/1/2013 6:43:19 AM
More...
|
Derma Sciences, Inc. (DSCI) Reports 2012 Fourth Quarter and Full Year Financial Results
4/1/2013 6:25:01 AM
More...
|
Derma Sciences, Inc. (DSCI) to Present at the 25th Annual ROTH Conference
3/15/2013 6:28:40 AM
More...
|
Derma Sciences, Inc. (DSCI) to Present at the 25th Annual ROTH Conference
3/14/2013 10:50:26 AM
More...
|
Derma Sciences, Inc. (DSCI) Closes $36.4 Million Underwritten Public Offering of Common Stock
12/12/2012 7:37:27 AM
More...
|
Derma Sciences, Inc. (DSCI) Announces Pricing of Underwritten Public Offering of Common Stock
12/6/2012 11:54:45 AM
More...
|
|